237 related articles for article (PubMed ID: 26153398)
1. Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT Study.
de Jonge L; Garne E; Gini R; Jordan SE; Klungsoyr K; Loane M; Neville AJ; Pierini A; Puccini A; Thayer DS; Tucker D; Vinkel Hansen A; Bakker MK
Drug Saf; 2015 Nov; 38(11):1083-93. PubMed ID: 26153398
[TBL] [Abstract][Full Text] [Related]
2. EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medication.
Luteijn JM; Morris JK; Garne E; Given J; de Jong-van den Berg L; Addor MC; Bakker M; Barisic I; Gatt M; Klungsoyr K; Latos-Bielenska A; Lelong N; Nelen V; Neville A; O'Mahony M; Pierini A; Tucker D; de Walle H; Wiesel A; Loane M; Dolk H
Br J Clin Pharmacol; 2016 Oct; 82(4):1110-22. PubMed ID: 27353147
[TBL] [Abstract][Full Text] [Related]
3. Paper 6: EUROCAT member registries: organization and activities.
Greenlees R; Neville A; Addor MC; Amar E; Arriola L; Bakker M; Barisic I; Boyd PA; Calzolari E; Doray B; Draper E; Vollset SE; Garne E; Gatt M; Haeusler M; Kallen K; Khoshnood B; Latos-Bielenska A; Martinez-Frias ML; Materna-Kiryluk A; Dias CM; McDonnell B; Mullaney C; Nelen V; O'Mahony M; Pierini A; Queisser-Luft A; Randrianaivo-Ranjatoélina H; Rankin J; Rissmann A; Ritvanen A; Salvador J; Sipek A; Tucker D; Verellen-Dumoulin C; Wellesley D; Wertelecki W
Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1():S51-S100. PubMed ID: 21381185
[TBL] [Abstract][Full Text] [Related]
4. Paper 1: The EUROCAT network--organization and processes.
Boyd PA; Haeusler M; Barisic I; Loane M; Garne E; Dolk H
Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1():S2-15. PubMed ID: 21384531
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive investigation of congenital anomalies in cerebral palsy: protocol for a European-Australian population-based data linkage study (The Comprehensive CA-CP Study).
Goldsmith S; Garcia Jalon G; Badawi N; Blair E; Garne E; Gibson C; McIntyre S; Scott H; Smithers-Sheedy H; Andersen GL
BMJ Open; 2018 Jul; 8(7):e022190. PubMed ID: 30037879
[TBL] [Abstract][Full Text] [Related]
6. Paper 3: EUROCAT data quality indicators for population-based registries of congenital anomalies.
Loane M; Dolk H; Garne E; Greenlees R;
Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1():S23-30. PubMed ID: 21384530
[TBL] [Abstract][Full Text] [Related]
7. Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry.
de Jonge L; de Walle HE; de Jong-van den Berg LT; van Langen IM; Bakker MK
Drug Saf; 2015 Aug; 38(8):737-47. PubMed ID: 26041497
[TBL] [Abstract][Full Text] [Related]
8. Insulin analogues use in pregnancy among women with pregestational diabetes mellitus and risk of congenital anomaly: a retrospective population-based cohort study.
Wang H; Wender-Ozegowska E; Garne E; Morgan M; Loane M; Morris JK; Bakker MK; Gatt M; de Walle H; Jordan S; Materna-Kiryluk A; Nelen V; Thys G; Wiesel A; Dolk H; de Jong-van den Berg LTW
BMJ Open; 2018 Feb; 8(2):e014972. PubMed ID: 29478010
[TBL] [Abstract][Full Text] [Related]
9. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
[TBL] [Abstract][Full Text] [Related]
10. EUROlinkCAT protocol for a European population-based data linkage study investigating the survival, morbidity and education of children with congenital anomalies.
Morris JK; Garne E; Loane M; Barisic I; Densem J; Latos-Bieleńska A; Neville A; Pierini A; Rankin J; Rissmann A; de Walle H; Tan J; Given JE; Claridge H;
BMJ Open; 2021 Jun; 11(6):e047859. PubMed ID: 34183346
[TBL] [Abstract][Full Text] [Related]
11. Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomalies.
Claridge H; Tan J; Loane M; Garne E; Barisic I; Cavero-Carbonell C; Dias C; Gatt M; Jordan S; Khoshnood B; Kiuru-Kuhlefelt S; Klungsoyr K; Mokoroa Carollo O; Nelen V; Neville AJ; Pierini A; Randrianaivo H; Rissmann A; Tucker D; de Walle H; Wertelecki W; Morris JK
BMJ Open; 2023 Jul; 13(7):e071687. PubMed ID: 37500278
[TBL] [Abstract][Full Text] [Related]
12. EUROCAT website data on prenatal detection rates of congenital anomalies.
Garne E; Dolk H; Loane M; Boyd PA;
J Med Screen; 2010; 17(2):97-8. PubMed ID: 20660439
[TBL] [Abstract][Full Text] [Related]
13. Linking a European cohort of children born with congenital anomalies to vital statistics and mortality records: A EUROlinkCAT study.
Loane M; Given JE; Tan J; Reid A; Akhmedzhanova D; Astolfi G; Barišić I; Bertille N; Bonet LB; Carbonell CC; Carollo OM; Coi A; Densem J; Draper E; Garne E; Gatt M; Glinianaia SV; Heino A; Hond ED; Jordan S; Khoshnood B; Kiuru-Kuhlefelt S; Klungsøyr K; Lelong N; Lutke LR; Neville AJ; Ostapchuk L; Puccini A; Rissmann A; Santoro M; Scanlon I; Thys G; Tucker D; Urhoj SK; de Walle HEK; Wellesley D; Zurriaga O; Morris JK
PLoS One; 2021; 16(8):e0256535. PubMed ID: 34449798
[TBL] [Abstract][Full Text] [Related]
14. EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations.
Given JE; Loane M; Luteijn JM; Morris JK; de Jong van den Berg LT; Garne E; Addor MC; Barisic I; de Walle H; Gatt M; Klungsoyr K; Khoshnood B; Latos-Bielenska A; Nelen V; Neville AJ; O'Mahony M; Pierini A; Tucker D; Wiesel A; Dolk H
Br J Clin Pharmacol; 2016 Oct; 82(4):1094-109. PubMed ID: 27028286
[TBL] [Abstract][Full Text] [Related]
15. Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in Denmark.
Cavero-Carbonell C; Vinkel-Hansen A; Rabanque-Hernández MJ; Martos C; Garne E
Birth Defects Res; 2017 Apr; 109(6):452-459. PubMed ID: 28398707
[TBL] [Abstract][Full Text] [Related]
16. Prescriptions for insulin and insulin analogues in children with and without major congenital anomalies: a data linkage cohort study across six European regions.
Given J; Morris JK; Garne E; Ballardini E; Barrachina-Bonet L; Cavero-Carbonell C; Gissler M; Gorini F; Heino A; Jordan S; Neville AJ; Pierini A; Scanlon I; Tan J; Urhoj SK; Loane M
Eur J Pediatr; 2023 May; 182(5):2235-2244. PubMed ID: 36869270
[TBL] [Abstract][Full Text] [Related]
17. Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study.
Bergman JEH; Lutke LR; Gans ROB; Addor MC; Barisic I; Cavero-Carbonell C; Garne E; Gatt M; Klungsoyr K; Lelong N; Lynch C; Mokoroa O; Nelen V; Neville AJ; Pierini A; Randrianaivo H; Rissmann A; Tucker D; Wiesel A; Dolk H; Loane M; Bakker MK
Drug Saf; 2018 Apr; 41(4):415-427. PubMed ID: 29230691
[TBL] [Abstract][Full Text] [Related]
18. Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.
de Jonge L; Zetstra-van der Woude PA; Bos HJ; de Jong-van den Berg LT; Bakker MK
Drug Saf; 2013 Nov; 36(11):1069-78. PubMed ID: 23828658
[TBL] [Abstract][Full Text] [Related]
19. Validation of congenital anomaly coding in Canada's administrative databases compared with a congenital anomaly registry.
Metcalfe A; Sibbald B; Lowry RB; Tough S; Bernier FP
Birth Defects Res A Clin Mol Teratol; 2014 Feb; 100(2):59-66. PubMed ID: 24307632
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcomes after fetal exposure to antithyroid medications or levothyroxine.
Schurmann L; Hansen AV; Garne E
Early Hum Dev; 2016 Oct; 101():73-7. PubMed ID: 27416058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
